InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (57 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
57
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Kumar Neil, Director General. Director active across 1 company, notably BridgeBio Pharma, Inc.. Aggregated, 84 filings have been logged. Split: 0 buy · 57 sells. Total volume traded: €46.8m. Activity tracked since 5 January 2023. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kumar Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones84 en total
1900 títulos@ 81,1494 US$Common StockSEC:0001470831-26-000848:0
17.279 títulos@ 82,2104 US$Common StockSEC:0001470831-26-000848:1
14.602 títulos@ 82,9922 US$Common StockSEC:0001470831-26-000848:2
1199 títulos@ 83,7732 US$Common StockSEC:0001470831-26-000848:3
8100 títulos@ 83,8588 US$Common StockSEC:0001470831-26-000848:4
1800 títulos@ 84,6867 US$Common StockSEC:0001470831-26-000848:5
100 títulos@ 85,65 US$Common StockSEC:0001470831-26-000848:6
33.544 títulosCommon StockSEC:0001470831-26-000836:0
19.599 títulosCommon StockSEC:0001470831-26-000836:1
11.554 títulosCommon StockSEC:0001470831-26-000836:2
6520 títulosCommon StockSEC:0001470831-26-000836:3
36.237 títulos@ 79,86 US$0.019% mcap5.5% de su flujoCommon StockSEC:0001470831-26-000836:4
2200 títulos@ 65,7202 US$0.0009% mcap0.4% de su flujoCommon StockSEC:0001470831-26-000523:0
1429 títulos@ 66,723 US$0.0006% mcap0.3% de su flujoCommon StockSEC:0001470831-26-000523:1
15.921 títulos@ 67,7378 US$0.0067% mcap3.0% de su flujoCommon StockSEC:0001470831-26-000523:2
450 títulos@ 68,2697 US$0.0002% mcap0.1% de su flujoCommon StockSEC:0001470831-26-000523:3
15.921 títulos@ 67,7377 US$0.0067% mcap3.0% de su flujoCommon StockSEC:0001470831-26-000523:6
7147 títulos@ 67,199 US$0.0030% mcap1.3% de su flujoCommon StockSEC:0001470831-26-000523:8
8437 títulos@ 67,8848 US$0.0036% mcap1.6% de su flujoCommon StockSEC:0001470831-26-000523:9
4416 títulos@ 68,9593 US$0.0019% mcap0.9% de su flujoCommon StockSEC:0001470831-26-000523:10
7148 títulos@ 67,199 US$0.0030% mcap1.3% de su flujoCommon StockSEC:0001470831-26-000523:11
4415 títulos@ 68,9593 US$0.0019% mcap0.9% de su flujoCommon StockSEC:0001470831-26-000523:13
2200 títulos@ 65,7202 US$0.0009% mcap0.4% de su flujoCommon StockSEC:0001470831-26-000523:4
450 títulos@ 68,2697 US$0.0002% mcap0.1% de su flujoCommon StockSEC:0001470831-26-000523:7
1429 títulos@ 66,723 US$0.0006% mcap0.3% de su flujoCommon StockSEC:0001470831-26-000523:5
25 de 84 declaraciones
About Kumar Neil
Kumar Neil is Président et Directeur Général and Chief Executive Officer of BridgeBio Pharma, Inc. He has 72 filings in total, and across the sampled recent filings the dominant transaction nature is sell, with €0 of purchases and €43,600,562 of sales between 2021-05-18 and 2026-06-08.
